List of Tables
Table 1: ACR-EULAR Classification Criteria for Rheumatoid Arthritis, 2010 13
Table 2: RA Therapeutics Market, Global, Licensing Deals Valued over $10m, 2006–2017 101
Table 3: RA Therapeutics Market, Global, Co-development Deals Valued over $10m, 2006–2017 110
Table 4: RA Therapeutics Market, Global, All Pipeline Products, Discovery, 2016 112
Table 5: RA Therapeutics Market, Global, All Pipeline Products, Preclinical, 2016 115
Table 6: RA Therapeutics Market, Global, All Pipeline Products, Investigational New Drug, 2016 125
Table 7: RA Therapeutics Market, Global, All Pipeline Products, Phase I, 2016 125
Table 8: RA Therapeutics Market, Global, All Pipeline Products, Phase II, 2016 128
Table 9: RA Therapeutics Market, Global, All Pipeline Products, Phase III, 2016 130
Table 10: RA Therapeutics Market, Global, All Pipeline Products, Pre-registration, 2016 131
Table 11: RA Therapeutics Market, APAC, Market Forecast, 2016–2023 131
Table 12: RA Therapeutics Market, India, Market Forecast, 2016–2023 132
Table 13: RA Therapeutics Market, China, Market Forecast, 2016–2023 132
Table 14: RA Therapeutics Market, Australia, Market Forecast, 2016–2023 132
Table 15: RA Therapeutics Market, South Korea, Market Forecast, 2016–2023 133
Table 16: RA Therapeutics Market, Japan, Market Forecast, 2016–2023 133